tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Amsellem, 435 are a BUY (75%), 131 are a HOLD (22.59%), 14 are a SELL (2.41%).
Analyst David Amsellem, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 55.7% that have a potential upside of 28.9% achieved within 251 days.
David Amsellem’s has documented 1,145 price targets and ratings displayed on 55 stocks. The coverage is on Healthcare, Consumer Defensive, Financial Services sectors.
Most recent stock forecast was given on BIIB, Biogen.
Analyst best performing recommendations are on RVNC (REVANCE THE).
The best stock recommendation documented was for RVNC (REVANCE THE) at 8/9/2024. The price target of $6 was fulfilled within 3 days with a profit of $2.47 (69.97%) receiving and performance score of 233.24.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 29-Nov-2017
$8.5
$0.28 (3.41%)
4 years 11 months 25 days ago
(18-Nov-2021)
0/3 (0%)
$0.33 (4.04%)
Buy Since 17-Aug-2017
5 years 29 days ago
(13-Oct-2021)
3/7 (42.86%)
$9.25 (194.74%)
87
Hold Since 13-Oct-2021
$8
$-0.22 (-2.68%)
$10
5 years 29 days ago
(13-Oct-2021)
1/7 (14.29%)
$-0.07 (-0.87%)
6
Buy Since 12-Jan-2016
$8
$-0.22 (-2.68%)
$7
5 years 30 days ago
(13-Oct-2021)
4/5 (80%)
$-0.07 (-0.87%)
95
Buy Since 12-Nov-2018
$8
$-0.22 (-2.68%)
$20
5 years 30 days ago
(12-Oct-2021)
1/2 (50%)
$-0.08 (-0.99%)
7
Which stock is David Amsellem most bullish on?
Which stock is David Amsellem most reserved on?
What Year was the first public recommendation made by David Amsellem?
